“COMPARATIVE ASSESSMENT OF GEFITINIB AND ERLOTINIB THERAPY IN SUBJECTS WITH NON-SMALL CELL LUNG CARCINOMA”. International Research Journal of Pharmacy 14, no. 9 (September 2, 2023): 1–5. Accessed October 29, 2026. https://irjponline.org/index.php/irjp/article/view/64.